COVID-19相关急性呼吸窘迫综合征:是否需要不同的管理方法?
本文为观点文章,讨论COVID-19相关ARDS的表型异质性及通气策略。早期报告提示其有别于历史ARDS,但新证据表明无论是否合并COVID-19,ARDS患者呼吸系统力学特征大体相似。作者强烈推荐遵循基于证据的管理,在资源允许时结合床旁生理学指导。
要点
- COVID-19相关ARDS与历史ARDS的呼吸系统力学特征大体相似。
- 个性化肺保护性机械通气降低死亡率,是ARDS治疗基石。
- 无证据支持偏离当前通气管理范式,应遵循循证管理。
核心结论
- COVID-19相关ARDS与历史ARDS的呼吸系统力学特征大体相似,无证据支持偏离当前通气管理范式。
研究设计与样本
- 本文为观点文章,基于文献与近期讨论,未报告系统检索范围或样本量。
主要发现
- 早期报告提示COVID-19相关ARDS具有区别于历史ARDS的独特特征。
- 新出现的证据表明,无论是否合并COVID-19,ARDS患者的呼吸系统力学特征大体相似。
- 个性化肺保护性机械通气可降低死亡率,已成为ARDS治疗的主要手段。
临床怎么用
- 强烈推荐遵循基于证据的ARDS管理,在资源允许时结合床旁生理学指导通气策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The COVID-19 pandemic has seen a surge of patients with acute respiratory distress syndrome (ARDS) in intensive care units across the globe. As experience of managing patients with COVID-19-associated ARDS has grown, so too have efforts to classify patients according to respiratory system mechanics, with a view to optimising ventilatory management. Personalised lung-protective mechanical ventilation reduces mortality and has become the mainstay of treatment in ARDS. In this Viewpoint, we address ventilatory strategies in the context of recent discussions on phenotypic heterogeneity in patients with COVID-19-associated ARDS. Although early reports suggested that COVID-19-associated ARDS has distinctive features that set it apart from historical ARDS, emerging evidence indicates that the respiratory system mechanics of patients with ARDS, with or without COVID-19, are broadly similar. In the absence of evidence to support a shift away from the current paradigm of ventilatory management, we strongly recommend adherence to evidence-based management, informed by bedside physiology, as resources permit.
引用
- Fan E, Beitler JR, Brochard L, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med. 2020. PMID: 32645311. doi:10.1016/S2213-2600(20)30304-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。